HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of thimerosal recommendations on hospitals' neonatal hepatitis B vaccination policies.

Abstract
We describe neonatal hepatitis B virus (HBV) vaccine policies in Colorado before and after thimerosal recommendations, plans for use of thimerosal-free HBV vaccine, and nurses' awareness of high-risk criteria for HBV vaccination. The results suggest that fewer neonates are receiving HBV vaccine at birth hospitals.
AuthorsR M Brayden, K A Pearson, J S Jones, B L Renfrew, S Berman
JournalThe Journal of pediatrics (J Pediatr) Vol. 138 Issue 5 Pg. 752-5 (May 2001) ISSN: 0022-3476 [Print] United States
PMID11343056 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Hepatitis B Vaccines
  • Preservatives, Pharmaceutical
  • Thimerosal
Topics
  • Centers for Disease Control and Prevention, U.S.
  • Guideline Adherence (standards)
  • Hepatitis B (prevention & control)
  • Hepatitis B Vaccines (adverse effects, therapeutic use)
  • Hospitals, Maternity
  • Humans
  • Infant, Newborn
  • Preservatives, Pharmaceutical (adverse effects)
  • Public Health
  • Risk Factors
  • Thimerosal (adverse effects)
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: